Because there are many unknown contributors, the strategy to upregulate CCM genes might not work for all cases of sporadic CCM, especially those with CCM gene mutation or those with CCM downstream gene mutation, such as gain-of-function MEKK3 (MAP3K3) mutations (90, 91). This evidence concerns the gene MAP3K3 and cerebral cavernous malformation.